U.S. Physical Therapy Dirección

Dirección controles de criterios 3/4

El CEO de U.S. Physical Therapy's es Chris Reading , nombrado en Nov 2004, tiene una permanencia de 19.42 años. compensación anual total es $3.37M, compuesta por 28.4% salario y 71.6% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.67% de las acciones de la empresa, por valor de $10.43M. La antigüedad media del equipo directivo y de la junta directiva es de 6.1 años y 13.1 años, respectivamente.

Información clave

Chris Reading

Chief Executive Officer (CEO)

US$3.4m

Compensación total

Porcentaje del salario del CEO	28.4%
Permanencia del CEO	19.5yrs
Participación del CEO	0.7%
Permanencia media de la dirección	6.2yrs
Promedio de permanencia en la Junta Directiva	13.2yrs

Actualizaciones recientes de la dirección

Recent updates

Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)

May 05

A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)

Apr 21

Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?

Apr 07

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit

Mar 04

The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence

Dec 23

Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching

Dec 07

U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations

Oct 13

Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?

Aug 01

U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)

Jul 19

At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?

May 07

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 25% Below Its Share Price

Apr 16

U.S. Physical Therapy (NYSE:USPH) Has A Pretty Healthy Balance Sheet

Apr 01

Some Investors May Be Worried About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital

Mar 04

U.S. Physical Therapy beats Q4 top and bottom line estimates; initiates FY23 outlook

Feb 23

U.S. Physical Therapy: Needs To Illustrate Economic Reality Over Accounting Profit

Feb 12

Is Now An Opportune Moment To Examine U.S. Physical Therapy, Inc. (NYSE:USPH)?

Jan 24

We Think U.S. Physical Therapy (NYSE:USPH) Can Stay On Top Of Its Debt

Dec 20

Here's Why We Think U.S. Physical Therapy (NYSE:USPH) Is Well Worth Watching

Dec 05

U.S. Physical Therapy: Not The Most Comfortable Prospect

Nov 09

U.S. Physical Therapy acquires physical therapy practice for $19.3M

Nov 01

U.S. Physical Therapy says Hurricane Ian affected about 50 clinics, ~$395K in lost sales

Oct 17

What Is U.S. Physical Therapy, Inc.'s (NYSE:USPH) Share Price Doing?

Oct 05

U.S. Physical Therapy acquires two-clinic practice

Oct 03

We Think U.S. Physical Therapy (NYSE:USPH) Can Stay On Top Of Its Debt

Sep 03

U.S. Physical Therapy: All Is Not Over, Hold For Now

Aug 26

U.S. Physical Therapy goes ex-dividend tomorrow

Aug 16

Is There An Opportunity With U.S. Physical Therapy, Inc.'s (NYSE:USPH) 37% Undervaluation?

Jul 10

What Is U.S. Physical Therapy, Inc.'s (NYSE:USPH) Share Price Doing?

Jun 15

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Chris Reading en comparación con los beneficios de U.S. Physical Therapy?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	US$3m	US$959k	US$18m
Sep 30 2023	n/a	n/a	US$24m
Jun 30 2023	n/a	n/a	US$26m
Mar 31 2023	n/a	n/a	US$28m
Dec 31 2022	US$2m	US$926k	US$29m
Sep 30 2022	n/a	n/a	US$39m
Jun 30 2022	n/a	n/a	US$38m
Mar 31 2022	n/a	n/a	US$37m
Dec 31 2021	US$4m	US$896k	US$31m
Sep 30 2021	n/a	n/a	US$31m
Jun 30 2021	n/a	n/a	US$30m
Mar 31 2021	n/a	n/a	US$32m
Dec 31 2020	US$3m	US$676k	US$32m
Sep 30 2020	n/a	n/a	US$30m
Jun 30 2020	n/a	n/a	US$31m
Mar 31 2020	n/a	n/a	US$29m
Dec 31 2019	US$3m	US$769k	US$31m
Sep 30 2019	n/a	n/a	US$30m
Jun 30 2019	n/a	n/a	US$23m
Mar 31 2019	n/a	n/a	US$18m
Dec 31 2018	US$3m	US$739k	US$17m
Sep 30 2018	n/a	n/a	US$18m
Jun 30 2018	n/a	n/a	US$22m
Mar 31 2018	n/a	n/a	US$21m
Dec 31 2017	US$2m	US$720k	US$22m

Compensación vs. Mercado: La compensación total de Chris($USD3.37M) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD5.61M).

Compensación vs. Ingresos: La compensación de Chris ha aumentado más de un 20%, mientras que los beneficios de la empresa han caído más de un 20% en el último año.

CEO

Chris Reading (59 yo)

19.5yrs

Permanencia

US$3,372,377

Compensación

Mr. Christopher J. Reading, also known as Chris, has been the Chief Executive Officer and President of US Physical Therapy Inc. since November 1, 2004. Mr. Reading served as the Chief Operating Officer at...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Christopher Reading	President	19.5yrs	US$3.37m	0.67% $ 10.6m
Carey Hendrickson	Chief Financial Officer	3.5yrs	US$1.69m	0.14% $ 2.2m
Richard Binstein	Executive VP	13.3yrs	US$1.50m	0.10% $ 1.6m
Graham Reeve	Chief Operating Officer - West	6.2yrs	US$1.91m	0.17% $ 2.7m
Eric Williams	Chief Operating Officer - East	2.8yrs	US$1.79m	0.13% $ 2.0m
Jake Martinez	Senior Vice President of Finance & Accounting	2.1yrs	sin datos	sin datos
Chadd Pence	Senior Vice President of Information Systems	no data	sin datos	sin datos
Jayne Pool	Senior VP & Chief Compliance Officer	no data	sin datos	sin datos
Jason Anderson	Vice President of Human Resources	no data	sin datos	sin datos
Jon Bates	VP & Corporate Controller	17.5yrs	sin datos	sin datos

6.2yrs

Permanencia media

59yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de USPH es experimentado (6.1 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Christopher Reading	President	19.5yrs	US$3.37m	0.67% $ 10.6m
Edward Kuntz	Independent Chairman	9.8yrs	US$340.29k	0.038% $ 610.3k
Nancy Ham	Independent Director	less than a year	US$215.92k	0.0057% $ 90.8k
Clayton Trier	Independent Director	19.3yrs	US$269.29k	0.046% $ 739.2k
Bernard Harris	Independent Director	18.8yrs	US$264.29k	0.11% $ 1.8m
Kathleen Gilmartin	Independent Director	6yrs	US$256.54k	0.10% $ 1.6m
Reginald Swanson	Independent Director	16.7yrs	US$236.54k	0.12% $ 1.8m
Anne Motsenbocker	Independent Director	2.3yrs	US$239.04k	0.028% $ 443.4k

13.2yrs

Permanencia media

67.5yo

Promedio de edad

Junta con experiencia: Los miembros de la junta directiva de USPH son experimentados ( 13.1 años antigüedad media).

U.S. Physical Therapy Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Executive VP recently sold US$213k worth of stock

Executive VP notifies of intention to sell stock

Chief Operating Officer - West recently sold US$274k worth of stock

Chief Operating Officer - West recently sold US$452k worth of stock

Chief Operating Officer - West notifies of intention to sell stock

Recent updates

Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)

A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?

Executive VP recently sold US$213k worth of stock

Executive VP notifies of intention to sell stock

Price target increased by 9.0% to US$119

Chief Operating Officer - West recently sold US$274k worth of stock

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit

Upcoming dividend of US$0.44 per share

Fourth quarter dividend increased to US$0.44

New minor risk - Profit margin trend

Full year 2023 earnings: EPS misses analyst expectations

U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence

Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching

Now 20% undervalued after recent price drop

Price target decreased by 9.6% to US$110

Consensus EPS estimates fall by 10%

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 8, 2023

Price target decreased by 7.9% to US$118

Now 20% undervalued after recent price drop

U.S. Physical Therapy, Inc. to Report Q3, 2023 Results on Nov 07, 2023

U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations

Is U.S. Physical Therapy (NYSE:USPH) A Risky Investment?

U.S. Physical Therapy (NYSE:USPH) Could Be Struggling To Allocate Capital

Chief Operating Officer - West recently sold US$452k worth of stock

Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?

Chief Operating Officer - West notifies of intention to sell stock

Second quarter 2023 earnings: EPS misses analyst expectations

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 8, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in U.S. Physical Therapy, Inc. (NYSE:USPH) for $2.1 million.

Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?

U.S. Physical Therapy, Inc. to Report Q2, 2023 Results on Aug 08, 2023

U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 75% interest in Physical therapy practice with four clinics for $3.1 million

U.S. Physical Therapy, Inc. has completed a Follow-on Equity Offering in the amount of $150.00003 million.

Price target increased by 7.9% to US$119

U.S. Physical Therapy, Inc. Elects Nancy Ham to the Board of Directors

Upcoming dividend of US$0.43 per share at 1.6% yield

At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

U.S. Physical Therapy Declares Quarterly Dividend, Payable on June 9, 2023

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 25% Below Its Share Price

U.S. Physical Therapy (NYSE:USPH) Has A Pretty Healthy Balance Sheet

Independent Director recently sold US$463k worth of stock

Executive VP recently sold US$92k worth of stock

Some Investors May Be Worried About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital

Upcoming dividend of US$0.43 per share at 1.7% yield

Price target increased by 7.5% to US$110

Full year 2022 earnings: EPS misses analyst expectations

U.S. Physical Therapy beats Q4 top and bottom line estimates; initiates FY23 outlook

U.S. Physical Therapy: Needs To Illustrate Economic Reality Over Accounting Profit

U.S. Physical Therapy, Inc. to Report Q4, 2022 Results on Feb 22, 2023

Is Now An Opportune Moment To Examine U.S. Physical Therapy, Inc. (NYSE:USPH)?

Independent Director recently sold US$608k worth of stock

We Think U.S. Physical Therapy (NYSE:USPH) Can Stay On Top Of Its Debt

President recently sold US$900k worth of stock

Here's Why We Think U.S. Physical Therapy (NYSE:USPH) Is Well Worth Watching

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice from practice’s owners for $25 million.

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice for $25 million.

Independent Director notifies of intention to sell stock

Independent Director recently sold US$134k worth of stock

Insufficient new directors

President notifies of intention to sell stock

Upcoming dividend of US$0.41 per share

Chief Operating Officer - West recently sold US$162k worth of stock